Pharmacological Modulation of Humoral Immunity in a Nonhuman Primate Model of AAV Gene Transfer for Hemophilia B

Molecular Therapy - United States
doi 10.1038/mt.2012.84
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

AAV-mediated Gene Transfer for Hemophilia

Genetics in Medicine
MedicineGenetics
2002English

823. Factor IX Expression in Skeletal Muscle of a Subject With Severe Hemophilia B Ten Years After AAV Gene Transfer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

A Nonhuman Primate Model of Inherited Retinal Disease

Journal of Clinical Investigation
Medicine
2019English

Successful Attenuation of Humoral Immunity to Viral Capsid and Transgenic Protein Following AAV-mediated Gene Transfer With a Non-Depleting CD4 Antibody and Cyclosporine

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

331 Maternal-Fetal Transfer of Melatonin in the Nonhuman Primate

Pediatric Research
Child HealthPediatricsPerinatology
1978English

Liver-Directed Lentiviral Gene Therapy in a Dog Model of Hemophilia B

Science Translational Medicine
Medicine
2015English

Blinded by the Light: A Nonhuman Primate Model of Achromatopsia

Journal of Clinical Investigation
Medicine
2019English

Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

244. Factor VIII Immunogenicity Is a Barrier to AAV Gene Therapy for Hemophilia A

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy